Jeff A. Sloan, Ph.D. is Professor of Biostatistics and Oncology at the Mayo Clinic in Rochester, Minnesota. Dr. Sloan is also the Chair of the Quality of Life Research Initiative at the Mayo Clinic and the PROQOL Research Committee for the North Central Treatment Group and American College of Surgeons Group. Dr. Sloan was trained as a mathematical statistician, obtaining his doctorate from the University of Manitoba, Canada in 1991. He held appointments in the Faculty of Nursing at the University of Manitoba for 10 years before coming to the Mayo Clinic in 1995. He has over 20 years of experience as a statistical consultant and researcher into measurement issues and clinical trials. Dr. Sloan is also the lead statistician for the North Central Cancer Treatment Group (NCCTG) Cancer Control Program. Other areas of emphasis have included phase I clinical trials, pediatric oncology, and lung cancer. Widely published with over 300 peer-reviewed citations, Dr. Sloan has focused recent research activities on methods of assessing quality of life (QOL) of cancer patients and other patient-reported outcomes. Determining a clinically meaningful difference in these measures, exploring the relationship between patient-reported outcomes and genetic makeup, and finding ways to facilitate the incorporation of patient-reported outcomes into clinical research have been specific areas of interest within the past two years. Most recently Dr. Sloan’s research has demonstrated that simple single item measures of patient QOL domains are prognostic for survival.
Ever wonder what happens to graduate students after they graduate? Check out the where are they now page.